FDA approves Actavis' generic Inderal Patent office sends Pfizer “non-final” rejection letter for Lipitor Noven completes JDS purchase, names new board member FDA approves two generics from Glochem Industries NACDS thanks organizations opposed to early implementation of tamper-proof prescriptions FDA cites Novartis for distributing ‘misleading’ promotional card FDA grants tentative approval for Caraco's generic Prandin NACDS chief calls for ‘willing foot soldiers’ in pharmacy’s long campaign for recognition FDA accepts application for Sciele/Summers novel head lice treatment Amgen to reduce expenditures by $1.9 billion and cut staff by 12-14 percent First Previous 2689 2690 2691 2692 2693 Next Last